title: Amylin acts in the central nervous system to increase sympathetic nerve activity.
abstract: The pancreatic hormone amylin acts in the central nervous system (CNS) to decrease food intake and body weight. We hypothesized that amylin action in the CNS promotes energy expenditure by increasing the activity of the sympathetic nervous system. In mice, ip administration of amylin significantly increased c-Fos immunoreactivity in hypothalamic and brainstem nuclei. In addition, mice treated with intracerebroventricular (icv) amylin (0.1 and 0.2 nmol) exhibited a dose-related decrease in food intake and body weight, measured 4 and 24 hours after treatment. The icv injection of amylin also increased body temperature in mice. Using direct multifiber sympathetic nerve recording, we found that icv amylin elicited a significant and dose-dependent increase in sympathetic nerve activity (SNA) subserving thermogenic brown adipose tissue (BAT). Of note, icv injection of amylin also evoked a significant and dose-related increase in lumbar and renal SNA. Importantly, icv pretreatment with the amylin receptor antagonist AC187 (20 nmol) abolished the BAT SNA response induced by icv amylin, indicating that the sympathetic effects of amylin are receptor-mediated. Conversely, icv amylin-induced BAT SNA response was enhanced in mice overexpressing the amylin receptor subunit, RAMP1 (receptor-activity modifying protein 1), in the CNS. Our data demonstrate that CNS action of amylin regulates sympathetic nerve outflow to peripheral tissues involved in energy balance and cardiovascular function.
authors: Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.
authors: Caroline
authors: C
authors: Fernandes-Santos
authors: Zhongming
authors: Z
authors: Zhang
authors: Donald A
authors: DA
authors: Morgan
authors: Deng-Fu
authors: DF
authors: Guo
authors: Andrew F
authors: AF
authors: Russo
authors: Kamal
authors: K
authors: Rahmouni
mesh_terms: D002001:Adipose Tissue, Brown / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects / Q000378:metabolism*; D004435:Eating / Q000187:drug effects; D007150:Immunohistochemistry; D057967:Infusions, Intraventricular; D058228:Islet Amyloid Polypeptide / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010446:Peptide Fragments / Q000494:pharmacology; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics / Q000378:metabolism; D058262:Receptor Activity-Modifying Protein 1 / Q000235:genetics / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000378:metabolism*
chemical_list: D058228:Islet Amyloid Polypeptide; D010446:Peptide Fragments; D016760:Proto-Oncogene Proteins c-fos; C545505:Ramp1 protein, mouse; D058262:Receptor Activity-Modifying Protein 1; C087166:AC 187
references: J Hypertens. 2000 Nov;18(11):1611-20
references: 11081774
references: J Chem Neuroanat. 2004 Jul;27(4):217-36
references: 15261329
references: Biochem Soc Trans. 2004 Nov;32(Pt 5):865-7
references: 15494035
references: Peptides. 2008 Jun;29(6):1028-35
references: 18346817
references: Endocrinology. 2000 Feb;141(2):850-3
references: 10650969
references: Am J Physiol. 1996 Dec;271(6 Pt 2):R1654-9
references: 8997366
references: Lancet. 1987 Aug 1;2(8553):231-4
references: 2441214
references: Physiol Rev. 2010 Apr;90(2):513-57
references: 20393193
references: Regul Pept. 1995 Apr 14;56(2-3):167-74
references: 7652192
references: Neuroscience. 1994 Sep;62(2):553-67
references: 7830897
references: Biochem J. 2000 Oct 15;351 Pt 2:347-51
references: 11023820
references: J Clin Endocrinol Metab. 2007 Apr;92(4):1446-50
references: 17213278
references: J Neurosci. 2007 Mar 7;27(10):2693-703
references: 17344407
references: Am J Physiol Regul Integr Comp Physiol. 2004 Jan;286(1):R114-22
references: 12958059
references: Arch Neurol. 2009 Mar;66(3):306-10
references: 19273748
references: Am J Pathol. 1988 Jan;130(1):1-8
references: 3276206
references: Physiol Behav. 2006 Nov 30;89(4):465-71
references: 16697020
references: Am J Physiol Regul Integr Comp Physiol. 2001 Dec;281(6):R1833-43
references: 11705768
references: Brain Res. 2007 Aug 8;1162:76-84
references: 17617389
references: PLoS One. 2011;6(9):e24815
references: 21935471
references: Brain Res. 1991 Jan 25;539(2):352-4
references: 1675913
references: Diabetologia. 1989 Apr;32(4):240-4
references: 2668077
references: Int J Obes (Lond). 2011 Sep;35(9):1183-92
references: 21179001
references: Semin Cell Dev Biol. 2004 Jun;15(3):299-308
references: 15125893
references: Diabetes. 2011 Apr;60(4):1063-71
references: 21357463
references: Am J Physiol Regul Integr Comp Physiol. 2007 Nov;293(5):R1855-63
references: 17855496
references: Physiol Behav. 1998 Jun 15;64(4):557-61
references: 9761232
references: Peptides. 1991 Sep-Oct;12(5):919-24
references: 1800955
references: Diabetes. 1990 Jun;39(6):752-6
references: 2189768
references: Peptides. 1998;19(5):883-9
references: 9663454
references: Life Sci. 1993;52(21):1717-26
references: 8502117
references: Life Sci. 1995;57(22):1993-2001
references: 7475950
references: Am J Physiol. 1993 Jun;264(6 Pt 1):E943-50
references: 8333519
references: Am J Physiol. 1994 Jul;267(1 Pt 1):E156-64
references: 8048505
references: Science. 2002 Aug 2;297(5582):780-1
references: 12161638
references: Endocrinology. 2006 Dec;147(12):5855-64
references: 16935845
references: Endocrinology. 2001 Nov;142(11):5035
references: 11606473
references: Pharmacol Ther. 2006 Jan;109(1-2):173-97
references: 16111761
references: Am J Physiol Regul Integr Comp Physiol. 2004 Sep;287(3):R568-74
references: 15130879
references: Peptides. 1998;19(9):1533-40
references: 9864060
references: Diabetes Metab. 2004 Jun;30(3):215-27
references: 15223973
references: Mol Pharmacol. 1999 Jul;56(1):235-42
references: 10385705
references: Brain Res. 1993 Apr 2;607(1-2):185-8
references: 8097662
references: Diabetologia. 1997 Mar;40(3):256-61
references: 9084962
references: Regul Pept. 1997 Aug 29;71(3):171-4
references: 9350975
references: J Clin Invest. 2004 Sep;114(5):652-8
references: 15343383
references: Peptides. 1991 Jul-Aug;12(4):865-9
references: 1788148
references: Obesity (Silver Spring). 2010 Sep;18(9):1739-46
references: 20094043
references: J Pharmacol Exp Ther. 1994 Aug;270(2):779-87
references: 8071870
references: Biochem Biophys Res Commun. 1986 Nov 14;140(3):827-31
references: 3535798
references: Brain Res. 2004 Jan 30;997(1):97-102
references: 14715154